Core Laboratories Inc.
CLB
$16.45
$0.342.11%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.35% | 5.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.35% | 5.32% | |||
| Cost of Revenue | 1.16% | 4.25% | |||
| Gross Profit | 11.95% | 9.71% | |||
| SG&A Expenses | 2.10% | -23.97% | |||
| Depreciation & Amortization | -2.07% | -1.26% | |||
| Other Operating Expenses | -160.42% | 81.66% | |||
| Total Operating Expenses | 0.94% | 1.40% | |||
| Operating Income | 25.50% | 63.35% | |||
| Income Before Tax | 45.29% | 593.11% | |||
| Income Tax Expenses | 96.44% | 9.45% | |||
| Earnings from Continuing Operations | 36.13% | 15,362.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -763.64% | 85.20% | |||
| Net Income | 33.88% | 7,006.49% | |||
| EBIT | 25.50% | 63.35% | |||
| EBITDA | 19.34% | 42.53% | |||
| EPS Basic | 34.94% | 7,012.12% | |||
| Normalized Basic EPS | 27.85% | 121.53% | |||
| EPS Diluted | 36.36% | 6,766.67% | |||
| Normalized Diluted EPS | 27.58% | 118.14% | |||
| Average Basic Shares Outstanding | -0.79% | -0.30% | |||
| Average Diluted Shares Outstanding | -0.60% | 1.26% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.26% | 1.01% | |||